During his hedge fund's quarterly conference call, Pershing Square CEO Bill Ackman dropped a big hint about what's next for his largest position, Valeant Pharmaceuticals. "Fairly ... soon Valeant will have identified a new specialty pharmacy to handle" the business that once belonged to Philidor Pharmacy, Ackman said.